Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interventions for psoriatic arthritis.

G Jones1, M Crotty, P Brooks

  • 1Department of Rheumatology, Menzies Centre for Population Health Res, GPO Box 252C, Hobart, Tasmania, Australia, 7001. G.Jones@Menzies.utas.edu.au

The Cochrane Database of Systematic Reviews
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucose sensor with improved haemocompatibilty.

Biosensors & bioelectronics·2001
Same author

The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci.

Human immunology·2001
Same author

Expression of CYP27A, a gene encoding a vitamin D-25 hydroxylase in human liver and kidney.

Clinical endocrinology·2001
Same author

Measuring blood volume with fluorescent-labeled hydroxyethyl starch.

Critical care medicine·2001
Same author

Alterations in development, behavior, and physiology in Drosophila larva that have reduced ecdysone production.

Journal of neurophysiology·2001
Same author

Anti-varicella-zoster virus bicyclic nucleosides: replacement of furo by pyrro base reduces antiviral potency.

Antiviral chemistry & chemotherapy·2001
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Parenteral high dose methotrexate and salazopyrin show proven efficacy for psoriatic arthritis. Other treatments may be effective, but require further trials due to limited data and significant placebo effects.

Area of Science:

  • Rheumatology
  • Clinical Pharmacology

Background:

  • Psoriatic arthritis (PsA) is a chronic inflammatory condition.
  • Effective therapeutic options for PsA are crucial for managing disease activity and improving patient outcomes.

Purpose of the Study:

  • To systematically review the efficacy of various medications in treating psoriatic arthritis.
  • To identify treatments with demonstrated effectiveness based on randomized controlled trials.

Main Methods:

  • A comprehensive literature search was conducted in Medline and Excerpta Medica databases.
  • Randomized trials comparing salazopyrin, auranofin, etretinate, fumaric acid, IMI gold, azathioprine, and methotrexate were included.
  • Outcome measures included disease activity indices, joint counts, pain, disability, and radiographic changes.

Related Experiment Videos

Main Results:

  • Thirteen trials involving 1022 subjects were quantitatively analyzed.
  • Salazopyrin, azathioprine, and etretinate showed statistically significant improvements in a global disease activity index.
  • Parenteral high-dose methotrexate and salazopyrin demonstrated the most robust published efficacy.

Conclusions:

  • Parenteral high-dose methotrexate and salazopyrin are recommended for psoriatic arthritis based on current evidence.
  • Azathioprine, etretinate, and low-dose methotrexate may be effective but require further investigation.
  • The significant placebo response highlights the need for controlled trials in psoriatic arthritis management.